Skip to main content

Menu

Select a tool from the sidebar

Create your free account now!

Sign in to customize and use tools on the sidebar.

Sign InCreate free account
Bristol-Myers Squibb Company logo
BMY
Bristol-Myers Squibb Company
20:00:03
54 $
0.0000 (%0.00)
Previous Close: 55.28
Day Low₺53.44
Day High₺55.325
Bid
Ask
Overview
Technicals
Financial Statements
Comments
Archive

BMY: Bristol-Myers Squibb Company Financials

Bristol-Myers Squibb Company Income Statement

Total revenue
Net income
Gross margin TTM
67.65%
Operating margin TTM
26.34%
Net profit margin TTM
14.63%
Return on investment TTM
38.18%
Period end31/12/202531/12/202431/12/202331/12/2022
Total revenue48,194,000,00048,300,000,00045,006,000,00046,159,000,000
Operating income12,696,000,0009,658,000,0008,472,000,0009,271,000,000
Net income7,053,000,000-8,948,000,0008,025,000,0006,327,000,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Total revenue48,194,000,00048,300,000,00045,006,000,00046,159,000,000
Cost of revenue15,592,000,00020,868,000,00019,649,000,00019,669,000,000
Gross profit32,602,000,00027,432,000,00025,357,000,00026,490,000,000
Research and development expenses9,612,000,0009,782,000,0009,207,000,0009,411,000,000
General and administrative expenses5,660,000,0006,365,000,00000
Selling and marketing expenses1,584,000,0001,500,000,00000
Selling, general and administrative expenses7,244,000,0007,865,000,0007,678,000,0007,808,000,000
Other expenses3,050,000,000127,000,00000
Operating expenses19,906,000,00017,774,000,00016,885,000,00017,219,000,000
Cost and expenses35,498,000,00038,642,000,00036,534,000,00036,888,000,000
Net interest income-1,210,000,000-1,947,000,000-1,166,000,000-1,232,000,000
Interest income300,000,000000
Interest expense1,510,000,0001,947,000,0001,166,000,0001,232,000,000
Depreciation and amortization3,860,000,0009,600,000,0009,760,000,00010,276,000,000
EBITDA14,545,000,0003,168,000,00019,366,000,00019,221,000,000
EBIT10,684,000,000-6,432,000,0009,606,000,0008,945,000,000
Non-operating income (excl. interest)2,012,000,00016,090,000,000-1,134,000,000326,000,000
Operating income12,696,000,0009,658,000,0008,472,000,0009,271,000,000
Total other income/expenses (net)-3,368,000,000-18,037,000,000-32,000,000-1,558,000,000
Income before tax9,328,000,000-8,379,000,0008,440,000,0007,713,000,000
Income tax expense2,272,000,000554,000,000400,000,0001,368,000,000
Net income from continuing operations7,056,000,000-8,933,000,0008,040,000,0006,345,000,000
Net income from discontinued operations0000
Other adjustments to net income5,000,000000
Net income7,053,000,000-8,948,000,0008,025,000,0006,327,000,000
Net income deductions0000
Bottom line net income7,053,000,000-8,948,000,0008,025,000,0006,327,000,000
EPS3-443
Diluted EPS3-443
Weighted average shares outstanding2,041,000,0002,027,000,0002,069,000,0002,130,000,000
Weighted average diluted shares outstanding2,041,000,0002,027,000,0002,078,000,0002,146,000,000

Bristol-Myers Squibb Company Balance Sheet

Total assets
Total liabilities & equity
Liquidity ratio MRQ
—
Current ratio MRQ
—
Long-term debt / assets MRQ
42,850,000,000%
Total debt / assets MRQ
—
Period end31/12/202531/12/202431/12/202331/12/2022
Total assets90,038,000,00092,603,000,00095,159,000,00096,820,000,000
Total liabilities71,532,000,00076,215,000,00065,674,000,00065,702,000,000
Total equity18,473,000,00016,335,000,00029,430,000,00031,061,000,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Cash and cash equivalents10,209,000,00010,346,000,00011,464,000,0009,123,000,000
Short-term investments464,000,000513,000,000816,000,000130,000,000
Cash and short-term investments10,673,000,00010,859,000,00012,280,000,0009,253,000,000
Net receivables14,525,000,00014,424,000,00015,264,000,00013,937,000,000
Accounts receivable9,592,000,0009,012,000,0008,882,000,0008,151,000,000
Other receivables4,933,000,0005,412,000,0006,382,000,0005,786,000,000
Inventory2,690,000,0002,557,000,0002,662,000,0002,339,000,000
Prepaid expenses0000
Other current assets1,502,000,0001,940,000,0001,564,000,0001,744,000,000
Total current assets29,390,000,00029,780,000,00031,770,000,00027,273,000,000
Property, plant and equipment (net)9,125,000,0008,360,000,0008,036,000,0007,475,000,000
Goodwill21,754,000,00021,719,000,00021,169,000,00021,149,000,000
Intangible assets19,103,000,00023,643,000,00027,485,000,00036,355,000,000
Goodwill and intangible assets40,857,000,00045,362,000,00048,654,000,00057,504,000,000
Long-term investments2,507,000,0002,508,000,0002,499,000,0002,187,000,000
Tax assets5,378,000,0004,236,000,0002,768,000,0001,344,000,000
Other non-current assets2,781,000,0002,357,000,0001,432,000,0001,037,000,000
Total non-current assets60,648,000,00062,823,000,00063,389,000,00069,547,000,000
Other assets0000
Total assets90,038,000,00092,603,000,00095,159,000,00096,820,000,000
Total payables5,837,000,0006,374,000,0005,843,000,0005,178,000,000
Accounts payable3,575,000,0003,602,000,0003,259,000,0003,040,000,000
Other payables2,262,000,0002,772,000,0002,584,000,0002,138,000,000
Accrued expenses484,000,000572,000,000349,000,000321,000,000
Short-term debt2,261,000,0002,046,000,0003,119,000,0004,264,000,000
Capital lease obligations (current)202,000,000181,000,000162,000,000136,000,000
Tax payables979,000,0001,514,000,0001,371,000,000942,000,000
Deferred revenue0000
Other current liabilities14,633,000,00014,601,000,00012,789,000,00011,991,000,000
Total current liabilities23,417,000,00023,774,000,00022,262,000,00021,890,000,000
Long-term debt42,850,000,00047,603,000,00036,653,000,00035,056,000,000
Capital lease obligations (non-current)1,826,000,0001,370,000,0001,530,000,0001,261,000,000
Deferred revenue (non-current)169,000,000230,000,000300,000,000283,000,000
Deferred tax liabilities (non-current)222,000,000369,000,000338,000,0002,166,000,000
Other non-current liabilities3,048,000,0002,869,000,0004,591,000,0005,046,000,000
Total non-current liabilities48,115,000,00052,441,000,00043,412,000,00043,812,000,000
Other liabilities0000
Capital lease obligations2,028,000,0001,551,000,0001,692,000,0001,397,000,000
Total liabilities71,532,000,00076,215,000,00065,674,000,00065,702,000,000
Treasury stock-43,579,000,000-43,655,000,000-43,766,000,000-38,618,000,000
Preferred stock0000
Common stock292,000,000292,000,000292,000,000292,000,000
Retained earnings16,896,000,00014,912,000,00028,766,000,00025,503,000,000
Additional paid-in capital46,387,000,00046,024,000,00045,684,000,00045,165,000,000
Accumulated other comprehensive income/loss-1,523,000,000-1,238,000,000-1,546,000,000-1,281,000,000
Other stockholders' equity0000
Total stockholders' equity18,473,000,00016,335,000,00029,430,000,00031,061,000,000
Total equity18,506,000,00016,388,000,00029,485,000,00031,118,000,000
Minority interest33,000,00053,000,00055,000,00057,000,000
Total liabilities and total equity90,038,000,00092,603,000,00095,159,000,00096,820,000,000
Total investments2,971,000,0003,021,000,0003,315,000,0002,317,000,000
Total debt47,139,000,00051,200,000,00041,464,000,00040,717,000,000
Net debt36,930,000,00040,854,000,00030,000,000,00031,594,000,000

Bristol-Myers Squibb Company Cash Flow Statement

Cash from operations
Cash from investing
Cash flow / share TTM
—
Revenue / share TTM
—
Operating cash flow TTM
—
Period end31/12/202531/12/202431/12/202331/12/2022
Cash from operations14,156,000,00015,190,000,00013,860,000,00013,066,000,000
Cash from investing-4,132,000,000-21,352,000,000-2,295,000,000-1,062,000,000
Cash from financing-10,348,000,0005,127,000,000-9,416,000,000-16,962,000,000
Net change in cash-137,000,000-1,172,000,0002,194,000,000-4,991,000,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Net income7,055,000,000-8,933,000,0008,040,000,0006,345,000,000
Depreciation and amortization4,011,000,0009,600,000,0009,760,000,00010,276,000,000
Deferred income tax-965,000,000-2,089,000,000-3,288,000,000-2,738,000,000
Stock-based compensation553,000,000507,000,000518,000,000457,000,000
Change in working capital-455,000,000810,000,000-1,914,000,000-2,229,000,000
Accounts receivable-295,000,000264,000,000-995,000,000-663,000,000
Inventory-184,000,000-486,000,000-751,000,000-69,000,000
Accounts payable-2,000,000184,000,000198,000,000109,000,000
Other working capital26,000,000848,000,000-366,000,000-1,606,000,000
Other non-cash items3,957,000,00015,295,000,000744,000,000955,000,000
Net cash from operating activities14,156,000,00015,190,000,00013,860,000,00013,066,000,000
Investments in property, plant and equipment-1,311,000,000-1,248,000,000-1,209,000,000-1,118,000,000
Acquisitions (net)-2,873,000,000-20,722,000,000-260,000,000-2,981,000,000
Purchases of investments-2,000,000,000-769,000,000-1,774,000,000-3,592,000,000
Sales/maturities of investments2,052,000,0001,387,000,000948,000,0006,629,000,000
Other investing activities0000
Net cash from investing activities-4,132,000,000-21,352,000,000-2,295,000,000-1,062,000,000
Net debt issuance-5,175,000,00010,096,000,000456,000,000-5,311,000,000
Long-term net debt issuance-5,200,000,00010,010,000,000576,000,000-5,505,000,000
Short-term net debt issuance25,000,00086,000,000-120,000,000194,000,000
Net stock issuance-128,000,0000-5,155,000,000-8,001,000,000
Net common stock issuance-128,000,0000-5,155,000,000-8,001,000,000
Common stock issuance-128,000,000000
Common stock repurchased00-5,155,000,000-8,001,000,000
Net preferred stock issuance0000
Net dividends paid-5,045,000,000-4,863,000,000-4,744,000,000-4,634,000,000
Common dividends paid-5,045,000,000-4,863,000,000-4,744,000,000-4,634,000,000
Preferred dividends paid0000
Other financing activities0-106,000,00027,000,000984,000,000
Net cash from financing activities-10,348,000,0005,127,000,000-9,416,000,000-16,962,000,000
Effect of FX changes on cash187,000,000-137,000,00045,000,000-33,000,000
Net change in cash-137,000,000-1,172,000,0002,194,000,000-4,991,000,000
Cash at end of period10,218,000,00010,347,000,00011,519,000,0009,325,000,000
Cash at beginning of period10,347,000,00011,519,000,0009,325,000,00014,316,000,000
Operating cash flow14,156,000,00015,190,000,00013,860,000,00013,066,000,000
Capital expenditure-1,311,000,000-1,248,000,000-1,209,000,000-1,118,000,000
Free cash flow12,845,000,00013,942,000,00012,651,000,00011,948,000,000
Income taxes paid0000
Interest paid0000